Oncology Reports, 1791-2431

Tidskrift

Fler filtreringsmöjligheter
  1. 1995
  2. Adipose tissue concentrations of dioxins and dibenzofurans in potentially exposed patients with malignant lymphoma or sarcoma

    L. Hardell, M. Eriksson, L. Athlin, M. Hansson & C. Rappe, 1995 jan 1, I : Oncology Reports. 2, 5, s. 749-753

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 1998
  4. Increased cancer incidence in physicians, dentists, and health care workers

    Mikael Eriksson, Lennart Hardell, Hans Malker & Jan Weiner, 1998 okt 27, I : Oncology Reports. 5, 6, s. 1413-1418

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 1999
  6. Occupational exposures as risk factors for oral cancer evaluated in a Swedish case-control study.

    E. B. Schildt, M. Eriksson, L. Hardell & Anders Magnuson, 1999 jan 1, I : Oncology Reports. 6, 2, s. 317-320

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2004
  8. Expression of DOL54 is not restricted to myxoid liposarcomas with the FUS-DDIT3 chimera but is found in various sarcomas.1

    Ioannis Panagopoulos, Fredrik Mertens, Margareth Isaksson & Nils Mandahl, 2004, I : Oncology Reports. 12, 1, s. 107-110

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2005
  10. Oncostatin M signaling in human glioma cell lines

    A Krona, Sofia Järnum, Leif Salford, Bengt Widegren & P Aman, 2005, I : Oncology Reports. 13, 5, s. 807-811

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Atypical lipomatous tumor with rare structural rearrangements involving chromosomes 8 and 12

    Malin A Nilsson, Henryk Domanski, Fredrik Mertens & Nils Mandahl, 2005 apr, I : Oncology Reports. 13, 4, s. 649-652 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2006
  13. Cystatins in non-small cell lung cancer: Tissue levels, localization and relation to prognosis

    Bernd Werle, Ulrike Schanzenbaecher, Tamara Turensek Lah, Eileen Ebert, Britta Juelke, Werner Ebert, Werner Fiehn, Klaus Kayser, Eberhard Spiess, Magnus Abrahamson & Janko Kos, 2006, I : Oncology Reports. 16, 4, s. 647-655

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survival.

    Janna Sand-Dejmek & Annika Dejmek, 2006, I : Oncology Reports. 15, 3, s. 583-587

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2008
  16. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland

    Magdalena Ratajska, Izabela Brozek, Elzbieta Senkus-Konefka, Jacek Jassem, Magdalena Stepnowska, Grazia Palomba, Marina Pisano, Milena Casula, Giuseppe Palmieri, Åke Borg & Janusz Limon, 2008, I : Oncology Reports. 19, 1, s. 263-268

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1.

    Ioannis Panagopoulos, Emely Möller, Anna Collin & Fredrik Mertens, 2008, I : Oncology Reports. 20, 5, s. 1029-1033

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2009
  19. Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma

    Karin Hardell, Michael Carlberg, Lennart Hardell, Helen Bjornfoth, Ingrid Ericson Jogsten, Mikael Eriksson, Bert Van Bavel & Gunilla Lindstrom, 2009, I : Oncology Reports. 21, 6, s. 1567-1576

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Bidirectionality and transcriptional activity of the EWSR1 promoter region

    Emely Möller, Nils Mandahl, Mariola Iliszko, Fredrik Mertens & Ioannis Panagopoulos, 2009 mar, I : Oncology Reports. 21, 3, s. 641-648 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Characterization of the human CREB3L2 gene promoter

    Ioannis Panagopoulos & Fredrik Mertens, 2009 mar, I : Oncology Reports. 21, 3, s. 615-624 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2010
  23. Characterization of an alternative transcript of the human CREB3L2 gene.

    Ioannis Panagopoulos, Nastaran Monsef, Anna Collin & Fredrik Mertens, 2010, I : Oncology Reports. 24, 5, s. 1133-1139

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Genetic profiles distinguish different types of hereditary ovarian cancer.

    Katarina Bartuma, Susanne Malander, Johan Staaf, Anna F Karlsson, Åke Borg, Göran B Jönsson & Mef Nilbert, 2010, I : Oncology Reports. 24, 4, s. 885-895

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2014
  26. Rearrangements of chromosome bands 15q12-q21 are secondary to HMGA2 deregulation in conventional lipoma.

    Gemma Macchia, Karolin Hansén Nord, Giuseppina D'Alessandro, Jenny Nilsson, Linda Magnusson, Nils Mandahl, Clelia Tiziana Storlazzi & Fredrik Mertens, 2014, I : Oncology Reports. 31, 2, s. 807-811

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2016
  28. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population

    Kristina Lagerstedt-Robinson, Anna Rohlin, Christos Aravidis, Beatrice Melin, Margareta Nordling, Marie Stenmark-Askmalm, Annika Lindblom & Mef Nilbert, 2016 nov 1, I : Oncology Reports. 36, 5, s. 2823-2835 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2019
  30. Engineered human mesenchymal stem cells for neuroblastoma therapeutics

    Valentina Nieddu, Roberta Piredda, Daniel Bexell, Jack Barton, John Anderson, Neil Sebire, Krishna Kolluri, Sam M. Janes, Emmanouil Karteris & Arturo Sala, 2019, I : Oncology Reports. 42, 1, s. 35-42 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift